BioSpace News Archive

According to Report, the global oxygen concentrators market size is set to hit USD 5,963.20 Million by 2027 and is estimated to expand at a modest CAGR of 5.80% during the prediction period 2021 to 2027.

The global prostate cancer therapeutics market was valued at USD 15.2 billion in 2021 and is projected to hit USD 24.9 billion by 2030 poised to grow at a CAGR of 9.4% from 2022 to 2030.

The global stem cells market was estimated at USD 12.53 billion in 2021 and it is projected to hit around USD 29.68 billion by 2030 poised to grow at a CAGR of 12.4% from 2022 to 2030.

ValnevaSE, a specialty vaccine company, today announced the initiation of a heterologous booster trial of its inactivated whole-virus COVID-19 vaccine candidate VLA2001.

Northwest Biotherapeutics (OTCQB: NWBO) (“NW Bio”), reported that a presentation entitled “Autologous Tumor Lysate-Loaded Dendritic Cell Vaccination for Glioblastoma” will be made on May 10, 2022 at 11:10 a.m., by Dr. Linda Liau at the Frontiers of Cancer Immunotherapy Conference of the New York Academy of Sciences.

Epic Sciences, Inc. has added DefineMBC™, a novel comprehensive blood-based test for characterizing metastatic breast cancer, to its CLIA laboratory menu.

Paradigm Biopharmaceuticals Ltd (ASX: PAR) (“Paradigm” or “the Company”), is pleased to report that the first subjects have been randomized and dosed in the United States (U.S.) in the PARA_OA_002 pivotal clinical trial, evaluating injectable pentosan polysulfate sodium (PPS/Zilosul®) for the treatment of pain associated with knee osteoarthritis (kOA).

uLab Systems™, the creator of the uSmile™ clear aligner system and the uDesign® treatment planning software, announces the upcoming release of uDesign 7.0, featuring AI-assisted Auto Staging and the uAssist digital assistant service.

BioSystics, Inc. , a recent spin-off from the University of Pittsburgh (UPitt), has been developing the Microphysiology Systems Database, the core of the BioSystics Analytics Platform (BioSystics-AP™), with funding over the last ten years from the National Center for Advancing Translational Sciences (NCATS).

Labcorp, a leading global life sciences company, announced that its Annual Meeting of Shareholders will be webcast live beginning May 11, at 9:00 a.m. ET.